Key result
Chronic norovirus GII.4 infection in an immunocompromised patient resulted in strong positive selection and intra-host viral evolution, producing novel variants with altered histo-blood group antigen and antigenic sites.
Why the study?
Immunocompromised patients are hypothesized to serve as important reservoirs for the emergence of new norovirus variants.
Case Report (n=1)
No
Chronically infected immunocompromised patients can serve as reservoirs for the emergence of novel norovirus variants driven by intra-host positive selection.
Answers are grounded in this paper and cite their sources.
Immunocompromised patients warrant targeted norovirus surveillance; this case report leaves open whether intra-host selection drives population-level variant emergence.
Human noroviruses (NVs) are the leading cause of acute gastroenteritis outbreaks worldwide. The majority of outbreaks are caused by genogroup II.4 (GII.4), with new variants emerging every 2 to 4 years. Immunocompromised patients are hypothesized to be important reservoirs where new NV variants emerge. Here, we examined intra-host NV variants and assessed immune-driven NV evolution in chronically infected immunocompromised hosts. Three NV GII.4-positive samples were collected from the same patient in different clinical phases following allogeneic hematopoietic stem cell transplantation, and had viral RNA concentrations of 2.46×106, 1.47×106, and 2.26×106 genome copies/mL. The non-synonymous (dN) and synonymous (dS) substitution ratio of the sequences in the partial P domain were >1, indicating strong positive selection in the patient. Both the number and the frequency of the single nucleotide variants increased over time in the patient. Also, the majority of capsid amino acid changes were located at blocking epitopes and histo-blood group antigen (HBGA)-binding sites, and 11 positive selection sites were found in the capsid region, of which 8 sites were presented in blocking epitopes or HBGA-bingding sites. Homodimeric P-domain capsid models also suggested a structural change in the epitopes and HBGA-binding sites. The results suggested that novel variants of NV GII.4 with HBGA and antigenic site changes were produced in the immunocompromised patient. Further functional and epidemiological studies are needed to determine whether the new variants are a risk to public health.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2020) conducted a case report in Chronic Norovirus GII.4 Infection (n=1). Chronic Norovirus GII.4 infection was evaluated on Intra-host viral evolution (dN/dS ratio and single nucleotide variants). Chronic norovirus GII.4 infection in an immunocompromised patient resulted in strong positive selection and intra-host viral evolution, producing novel variants with altered histo-blood group antigen and antigenic sites.
Synapse has enriched 10 related papers. Consider them for comparative context: